PlayStation State of Play February 2026: all the news and trailers
Strap in, because the next PlayStation event is going to be a long one. Sony’s latest State of Play — a showcase …
NExT
Read More
Next AI Catalyst is New Batch of Models: Weaver
Michelle Weaver, Head of US Thematic Research at Morgan Stanley, says the next AI catalyst to watch for is when the next …
SpaceX acquires xAI, plans to launch a massive satellite constellation to power it
“This marks not just the next chapter, but the next book in SpaceX and xAI’s mission.” Image: Min An / Pexels Source: …
From Blueprint to Brainchild: Zuckerberg Declares AI the Architect of Our Digital Future
Introduction In a strategic pivot echoing through Silicon Valley, Meta CEO Mark Zuckerberg has placed a monumental bet on artificial intelligence as …
The $6.6 Trillion Question: How the Next Fed Chair Will Navigate the Great Unwinding
Introduction As President Donald Trump prepares to name his nominee for the world’s most powerful economic post, a single, staggering figure looms …
Beyond the Phone: Apple’s Next Frontier Emerges as AI-Pinned Wearable Enters Development
Introduction In a move signaling its next major hardware evolution, Apple is reportedly deep in development of a groundbreaking wearable device. Codenamed …
Beyond the Glitz: How CES 2026 Became a Battlefield for the AI-Powered Future
Introduction Las Vegas is once again the epicenter of technological ambition, but CES 2026 has shed its skin as a mere gadget …
Beyond Blackwell: Nvidia’s Rubin Architecture Ushers in the ‘AI Factory’ Era
Introduction In a move that redefines the frontier of artificial intelligence, Nvidia has unveiled its next-generation Rubin computing platform. CEO Jensen Huang’s …
The Siri Ultimatum: Apple’s High-Stakes Bet on AI to Revive Its Upgrade Engine
Introduction In the high-stakes arena of artificial intelligence, Apple finds itself at a critical inflection point. The company’s next move isn’t just …
Bristol Myers Squibb: A Pharma Giant Trading Like Growth Is Over – It’s Not
Bristol Myers Squibb: A Pharma Giant Trading Like Growth Is Over – It’s Not The market narrative around Bristol Myers Squibb (BMY) …
- 1
- 2